At a glance
- A near-quadrupling inside seven years says as much about the market as about CVC: if the new pool is just short of four times its predecessor, the 2019 flagship cleared somewhere north of $2.5bn, and a re-rating at that pace implies that LPs stopped treating secondaries as opportunistic and started treating it as core.
- The whole market is living through that re-rating, and as this publication has argued, record secondaries capital is now chasing a shrinking pool of true price discovery.
- Capital that cannot clear in classic LP trades tends to migrate to GP-led continuations, NAV loans, collateralized fund obligations and minority-stake sales — the corners of the market where the sponsor selling the asset also supplies the marks on it, and where the discipline of an independent price is weakest.
CVC's secondaries flagship has reached $10bn, AltAssets reported on 3 September, a raise that puts the vehicle at nearly four times the size of the fund the firm closed in 2019. A near-quadrupling inside seven years says as much about the market as about CVC: if the new pool is just short of four times its predecessor, the 2019 flagship cleared somewhere north of $2.5bn, and a re-rating at that pace implies that LPs stopped treating secondaries as opportunistic and started treating it as core.
The whole market is living through that re-rating, and as this publication has argued, record secondaries capital is now chasing a shrinking pool of true price discovery. When commitments outrun the supply of assets worth buying at defensible prices, the price of quality rises until the trade clears on terms the seller can dictate.
Those seller-side terms are where risk concentrates. Capital that cannot clear in classic LP trades tends to migrate to GP-led continuations, NAV loans, collateralized fund obligations and minority-stake sales — the corners of the market where the sponsor selling the asset also supplies the marks on it, and where the discipline of an independent price is weakest.
At $10bn, that pressure lands on CVC as much as on anyone, because scale buys access to the GP-led pipeline and a pick of continuation deals, but it also starts a deployment clock. A pool this size cannot wait indefinitely for the quality end of the market to widen, and in a thin market the temptation is to accept the price in front of it.
The marker for this fund will be whether scale behaves like patience or like pressure. If CVC can let deals pass when valuations run ahead of what a competitive process would support, the near-quadrupling is genuine strength. If it cannot, the $10bn milestone will read as expensive evidence that secondaries fundraising has outrun its own price discovery.
Reported by the Fundraising desk from AltAssets. Published . Corrections